These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21743491)

  • 1. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.
    Lu D; Han C; Wu T
    Oncogene; 2012 Feb; 31(7):842-57. PubMed ID: 21743491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
    Lu D; Han C; Wu T
    Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15d-PGJ₂ decreases PGE₂ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter.
    Liu C; Chen S; Wang X; Chen Y; Tang N
    Biochem Pharmacol; 2014 Oct; 91(3):337-47. PubMed ID: 25108236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K; Han C; Dai Y; Shen M; Wu T
    Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
    Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
    Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.
    Sasaki Y; Kamei D; Ishikawa Y; Ishii T; Uematsu S; Akira S; Murakami M; Hara S
    Oncogene; 2012 Jun; 31(24):2943-52. PubMed ID: 21986945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
    Hanaka H; Pawelzik SC; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjörnsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson PJ; Kogner P; Rådmark O
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18757-62. PubMed ID: 19846775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis.
    Nakanishi M; Montrose DC; Clark P; Nambiar PR; Belinsky GS; Claffey KP; Xu D; Rosenberg DW
    Cancer Res; 2008 May; 68(9):3251-9. PubMed ID: 18451151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation.
    Sha W; Olesch C; Hanaka H; Rådmark O; Weigert A; Brüne B
    Int J Cancer; 2013 Oct; 133(7):1578-88. PubMed ID: 23536473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
    Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
    Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma.
    Takii Y; Abiru S; Fujioka H; Nakamura M; Komori A; Ito M; Taniguchi K; Daikoku M; Meda Y; Ohata K; Yano K; Shimoda S; Yatsuhashi H; Ishibashi H; Migita K
    Liver Int; 2007 Sep; 27(7):989-96. PubMed ID: 17696939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1.
    Deckmann K; Rörsch F; Geisslinger G; Grösch S
    Cell Signal; 2012 Feb; 24(2):460-467. PubMed ID: 21983014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
    Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of mPGES-1 in the occurrence, progression, metastasis and invasion of hepatocellular carcinoma].
    Lian YE; Liu JF; Wang XJ; Zang SB; Huang AM
    Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):356-61. PubMed ID: 21645444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
    Moon Y; Glasgow WC; Eling TE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.